Table 1. Characteristics of the eligible studies in the meta-analysis.
| First author | Year | Country | Recruitment Period |
Autologous BT (n) |
Allogeneic BT (n) |
Survival analysis |
Quality score |
|---|---|---|---|---|---|---|---|
| Ford BS | 2008 | USA | 1987–2005 | 252 | 117 | BRFS | 7 |
| Boehm K | 2015 | Germany | 1992–2011 | 548 | 445 | BRFS, OS | 7 |
| Yeoh TY | 2014 | Singapore | 1991–2005 | - | 379 | OS, CSS | 8 |
| Gallina A | 2007 | Germany | 1992–2005 | 205 | - | BRFS | 6 |
| Chalfin HJ | 2014 | USA | 1994–2012 | 5,124 | 258 | BRFS, OS, CSS | 9 |
| McClinton S | 1990 | UK | 1977–1982 | - | 71 | OS | 6 |
| Oefelein MG | 1995 | USA | 1980–1990 | 62 | 153 | BRFS, CSS | 7 |
| Eickhoff JH | 1991 | Denmark | 1978–1986 | - | 60 | OS, CSS | 6 |
| Paul R | 2006 | Germany | 1984–2003 | 45 | 756 | BRFS | 6 |
| Kim JK | 2016 | Korea | 1993–2014 | 90 | 350 | BRFS, OS, CSS | 8 |